Hydreight Technologies Statistics

Total Valuation

TSXV:NURS has a market cap or net worth of CAD 195.91 million. The enterprise value is 185.60 million.

Market Cap	195.91M
Enterprise Value	185.60M

Important Dates

The last earnings date was Friday, November 21, 2025.

Earnings Date	Nov 21, 2025
Ex-Dividend Date	n/a

Share Statistics

TSXV:NURS has 47.32 million shares outstanding. The number of shares has increased by 13.27% in one year.

Current Share Class	47.32M
Shares Outstanding	47.32M
Shares Change (YoY)	+13.27%
Shares Change (QoQ)	+4.97%
Owned by Insiders (%)	3.28%
Owned by Institutions (%)	1.10%
Float	20.45M

Valuation Ratios

The trailing PE ratio is 432.25 and the forward PE ratio is 20.70.

PE Ratio	432.25
Forward PE	20.70
PS Ratio	8.00
PB Ratio	20.68
P/TBV Ratio	27.33
P/FCF Ratio	270.01
P/OCF Ratio	269.27
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 247.50, with an EV/FCF ratio of 255.80.

EV / Earnings	409.50
EV / Sales	7.58
EV / EBITDA	247.50
EV / EBIT	n/a
EV / FCF	255.80

Financial Position

The company has a current ratio of 4.47, with a Debt / Equity ratio of 0.88.

Current Ratio	4.47
Quick Ratio	4.26
Debt / Equity	0.88
Debt / EBITDA	11.10
Debt / FCF	11.47
Interest Coverage	2.70

Financial Efficiency

Return on equity (ROE) is 11.78% and return on invested capital (ROIC) is 2.83%.

Return on Equity (ROE)	11.78%
Return on Assets (ROA)	1.81%
Return on Invested Capital (ROIC)	2.83%
Return on Capital Employed (ROCE)	2.03%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.95
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +279.82% in the last 52 weeks. The beta is 0.60, so TSXV:NURS's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	+279.82%
50-Day Moving Average	4.56
200-Day Moving Average	2.74
Relative Strength Index (RSI)	44.30
Average Volume (20 Days)	173,346

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSXV:NURS had revenue of CAD 24.48 million and earned 453,235 in profits. Earnings per share was 0.01.

Revenue	24.48M
Gross Profit	7.14M
Operating Income	362,248
Pretax Income	453,235
Net Income	453,235
EBITDA	749,891
EBIT	362,248
Earnings Per Share (EPS)	0.01

Full Income Statement

Balance Sheet

The company has 18.64 million in cash and 8.32 million in debt, giving a net cash position of 10.31 million or 0.22 per share.

Cash & Cash Equivalents	18.64M
Total Debt	8.32M
Net Cash	10.31M
Net Cash Per Share	0.22
Equity (Book Value)	9.47M
Book Value Per Share	0.20
Working Capital	15.50M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 727,566 and capital expenditures -1,995, giving a free cash flow of 725,571.

Operating Cash Flow	727,566
Capital Expenditures	-1,995
Free Cash Flow	725,571
FCF Per Share	0.02

Full Cash Flow Statement

Margins

Gross margin is 29.16%, with operating and profit margins of 1.48% and 1.85%.

Gross Margin	29.16%
Operating Margin	1.48%
Pretax Margin	1.85%
Profit Margin	1.85%
EBITDA Margin	3.06%
EBIT Margin	1.48%
FCF Margin	2.96%

Dividends & Yields

TSXV:NURS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.27%
Shareholder Yield	-13.27%
Earnings Yield	0.23%
FCF Yield	0.37%

Stock Splits

The last stock split was on November 25, 2022. It was a reverse split with a ratio of 0.1546061.

Last Split Date	Nov 25, 2022
Split Type	Reverse
Split Ratio	0.1546061

Scores

TSXV:NURS has an Altman Z-Score of 5.21 and a Piotroski F-Score of 5.

Altman Z-Score	5.21
Piotroski F-Score	5